Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
271M
-
Number of holders
-
127
-
Total shares
-
75.7M
-
Shares change
-
+651K
-
Total reported value, excl. options
-
$84.7M
-
Value change
-
+$1.03M
-
Put/Call ratio
-
0.04
-
Number of buys
-
58
-
Number of sells
-
-45
-
Price
-
$1.12
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q4 2024
152 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q4 2024.
PRECIGEN, INC. - Common Stock (PGEN) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.7M shares
of 271M outstanding shares and own 27.97% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (17.9M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (10.9M shares), BlackRock, Inc. (10.4M shares), VANGUARD GROUP INC (8.33M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (5.24M shares), GEODE CAPITAL MANAGEMENT, LLC (3.3M shares), STATE STREET CORP (2.97M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.28M shares), NORTHERN TRUST CORP (1.17M shares), and MORGAN STANLEY (1.12M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.